• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pacific Therapeutics Ltd

+ Add to Watchlist


0.026 EUR 0.004 18.18%

As of 10:52:51 ET on 11/28/2014.

Snapshot for Pacific Therapeutics Ltd (1P3)

Open: 0.022 Day's Range: 0.016 - 0.026 Volume: 20,000
Previous Close: 0.022 52wk Range: 0.006 - 0.068 1-Yr Rtn: -54.39%

Stock Chart for 1P3

No chart data available.
  • 1P3:GR 0.026
  • 1D
  • 1M
  • 1Y
Interactive 1P3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 1P3

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.69
Shares Outstanding (M) 26.59
30 Day Average Volume 8,949
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 1P3

No data available

Company Profile & Key Executives for 1P3

Pacific Therapeutics Ltd. is a development stage specialty pharmaceutical company. The Company is involved in the identification and development of drug candidates to treat diseases of excessive scarring including Idiopathic Pulmonary Fibrosis.

Douglas H Unwin "Doug"President/CEODerick Graham SinclairChief Financial Officer
More Company Profile & Key Executives for 1P3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • 1P3 News

  • Industry News

No stories found
No stories found
Sponsored Links
sec ||= nil